Clinical Trial

Sleep, Glucose, and Brain Health in Obesity and Overweight Individuals

Study acronym: NNF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of the NNF study is to investigate both cross-sectional and longitudinal associations between sleep patterns-measured over two consecutive weeks at baseline and again one year later-and indicators of glycemic control and brain health in a cohort of middle-aged adults. Through this effort, the investigators hope to identify potential sleep-related biomarkers and behavioral targets for early intervention to support metabolic and cognitive health.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-05.
Trial Details
NCT Number NCT06968728
Lead Sponsor Uppsala University
Conditions Obesity and Overweight, Type 2 Diabetes, Sleep, Brain Health
Enrollment 400 participants
Start Date 2025-05-15
Primary Completion 2028-01-15 (estimated)
Study Completion 2030-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-18